Outlook for Generic Musculoskeletal Disorders Drugs Market: Key Developments and Future Strategies to 2029
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Does the Forecast Indicate for the Generic Musculoskeletal Disorders Drugs Market From 2025 to 2029?
The market size for generic musculoskeletal disorder medications has demonstrated significant growth in the past few years. It is projected to expand from $0.06 billion in 2024 to $0.06 billion in 2025, reflecting a compound annual growth rate (CAGR) of 5.7%. Factors contributing to this growth during the historical period include the prevalence of musculoskeletal disorders, regulatory landscape, advancements in healthcare infrastructure, patient education and awareness, and economic conditions.
There is a forecast of significant expansion for the generic musculoskeletal disorders drugs market in the coming years. The market is projected to increase to $0.08 billion by 2029, with a compound annual growth rate (CAGR) of 6.9%. This growth during the forecast period can be associated with several factors, including population growth and aging, the rise of emerging markets, precision medicine and personalized therapies, healthcare reforms, and global health trends. The predominant market directions in the forecast period would involve the integration of technology in treatments, governmental initiatives, and healthcare policies, emphasis on alternative pain management, broader adoption of biosimilars, and progress in generic drug development.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9433&type=smp
What Elements Are Contributing To Growth In The Generic Musculoskeletal Disorders Drugs Market?
The anticipated expansion of the generic musculoskeletal disorders drugs market is tied to the high frequency of arthritis cases. Arthritis, characterized by joint tenderness, swelling, pain and stiffness, finds relief in these drugs as they alleviate these symptoms and treat muscle spasms prevalent in afflicted individuals. For example, Versus Arthritis, a charity based out of the UK, reported in March 2022 that around 10 million UK inhabitants have been diagnosed with osteoarthritis. This includes 5.4 million with knee OA and 3.2 million with hip OA. In addition, roughly 450,000 suffer from rheumatoid arthritis and 190,000 from psoriatic arthritis. This contributes to the stark figure of over 20 million individuals living with musculoskeletal conditions. Consequently, there are over 30 million prescriptions for these conditions costing around £139 million in 2022-2023. As such, the high occurrence rate of arthritis continues to fuel the growth of the generic musculoskeletal disorders drugs market.
Which Segments Are Detailed In The Global Generic Musculoskeletal Disorders Drugs Market Report?
The generic musculoskeletal disorders drugs market covered in this report is segmented –
1) By Treatment Type: Medication, Therapy, Surgery, Other Treatment Types
2) By Disorder Type: Osteoarthritis, Rheumatoid Arthritis, Spondylarthritis, Juvenile Idiopathic Arthritis, Psoriatic Arthritis, Fibromyalgia, Other Disorder Types
3) By Route Of Administration: Oral, Parenteral, Other Routes
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Drug Store, Online Pharmacy
Subsegments:
1) By Medication: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Analgesics, Corticosteroids, Disease-Modifying Antirheumatic Drugs (DMARDs), Biologics
2) By Therapy: Physical Therapy, Occupational Therapy, Chiropractic Treatment, Massage Therapy
3) By Surgery: Joint Replacement Surgery, Arthroscopy, Spinal Surgery, Fusion Surgery
4) By Other Treatment Types: Lifestyle Modifications, Alternative Therapies, Assistive Devices
Which Emerging Trends And Strategic Shifts Are Shaping The Generic Musculoskeletal Disorders Drugs Market?
A rising trend in the generic musculoskeletal disorders drugs market is the strategic collaborations between companies. Many firms in this market are forming partnerships with others to fortify their market position. For example, Mitsubishi Tanabe Pharma Corporation, a pharmaceutical firm based in Japan, formed a partnership with the US pharmaceutical company, Eli Lilly and Company, in July 2022. This collaboration aids both companies in expanding their product offerings and providing efficacious treatments for diseases such as diabetes among others. Similarly, in February 2022, Pfizer Inc., a pharmaceutical and biotechnology firm from the US, allied with Alex Therapeutics, a digital therapeutics firm from Sweden. This strategic business alliance provides patients with evidence-based, clinically proven, and personalised digital therapeutics.
Who Are The Key Contributors To Growth In The Generic Musculoskeletal Disorders Drugs Market?
Major companies operating in the generic musculoskeletal disorders drugs market include Pfizer Inc., Sanofi S.A., Eli Lilly and Company, Ampio Pharmaceuticals Inc., Amgen Inc., Boehringer Ingelheim International GmbH, Merck & Co. Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceuticals Industries Ltd., AstraZeneca plc, Mitsubishi Tanabe Pharma Corporation, Horizon Therapeutics plc, Eisai Co. Ltd., Biogen Inc., Sino Biopharmaceutical Limited, Bristol-Myers Squibb Company, Johnson & Johnson Services Inc., AbbVie Inc., Novartis AG, F. Hoffmann-La Roche Ltd., Bayer AG, Mylan Pharmaceuticals Inc., Taisho Pharmaceutical Holdings Co. Ltd., Flexion Therapeutics Inc.
Get The Full Report Here:
Which Region Is Projected To Lead The Generic Musculoskeletal Disorders Drugs Market By 2025?
Asia-Pacific was the largest region in the generic musculoskeletal disorders drugs market in 2024. The regions covered in the generic musculoskeletal disorders drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=9433&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
